Glenn (from left), Beckham, Cara and Eliza O'Neill pose for a family photo in 2015. Eliza has Sanfilippo syndrome, a rare inherited disease. Robert Clark hide caption
Sanfilippo syndrome is a rare and degenerative disease that can be fatal by the time someone reaches their teens. So the O'Neill family knew they didn't have much time after learning their 4-year old daughter, Eliza, had it. At the time no treatment existed, and the world of drug development had its eyes on more common illnesses. So the family took an all-hands-on-deck, unusual approach to directly raise money and boost medical research.
NPR pharmaceutical correspondent Sydney Lupkin joins Short Wave to share what happened next, and what she learned from the O'Neills story about the promises and challenges of drug development.
Interested in more medical science? Email us your question at [email protected] .
Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show's perks include sponsor-free listening. Learn more at plus.npr.org .
Listen to Short Wave on Spotify and Apple Podcasts .
This episode was produced by Elana Gordon. It was edited by Rebecca Ramirez. Tyler Jones checked the facts. The audio engineer was Jimmy Keeley.
NPR does not offer or accept money for coverage or interviews. Anyone who makes such an offer or request is not an NPR employee and does not represent NPR.